PedAM
Pediatric Disease Annotations & Medicines
| Disease | myasthenia gravis |
| Symptom | C0234119|neuromuscular block |
| Sentences | 5 |
| PubMedID- 21520600 | Sugammadex can be used to reverse rocuronium-induced neuromuscular blockade in patients with myasthenia gravis, thereby avoiding the need for reversal with acetylcholinesterase inhibitors. |
| PubMedID- 20105151 | Sugammadex, in combination with objective neuromuscular monitoring, can be used to reverse rocuronium-induced neuromuscular blockade in patients with myasthenia gravis, thereby avoiding the need for reversal with acetylcholinesterase inhibitors. |
| PubMedID- 25192270 | Reversal of neuromuscular blockade with sugammadex in patients with myasthenia gravis: a case series of 21 patients and review of the literature. |
| PubMedID- 22263413 | Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis. |
| PubMedID- 26086278 | Background: several previous studies using univariate analysis have suggested that the pre-anaesthetic train-of-four (tof) ratio, concentration of anti-acetylcholine receptor (achr) antibodies and the presence of preoperative generalised muscular involvement are determinants of an increased response to neuromuscular blocking agents (nmbas) in patients with myasthenia gravis. |
Page: 1